GERN · Geron Corp
$1.47
-0.07 (-4.23%)
At close · Aug 14
Market Cap
$944.44M
Shares
642.47M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Harout Semerjian | President and Chief Executive Officer (as of August 7, 2025) | $10,221,755 |
| John Scarlett | Former Chairman of the Board, President and Chief Executive Officer | $7,422,754 |
| Andrew J. Grethlein | Former Executive Vice President, Chief Operating Officer | $3,316,444 |
| Ahmed ElNawawi | Executive Vice President, Chief Commercial Officer (as of October 20, 2025) | $2,881,334 |
| James Ziegler | Former Executive Vice President, Chief Commercial Officer (as of September 9, 2024) | $2,392,709 |
| Michelle Robertson | CFO | $2,250,082 |
| Michelle J. Robertson | Executive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary | $2,250,082 |
| Joseph Eid | Executive Vice President, Research & Development, Chief Medical Officer (as of November 11, 2024) | $1,001,052 |
| Dawn C. Bir | Former Interim President and Chief Executive Officer (as of March 17, 2025) | $522,122 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joseph Eid | Executive Vice President, Research & Development (as of November 11, 2024) | $7,762,848 |
| John Scarlett | Former Chairman of the Board, President and Chief Executive Officer | $6,125,238 |
| James Ziegler | Executive Vice President, Chief Commercial Officer (as of September 9, 2024) | $5,768,744 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $2,813,956 |
| Michelle J. Robertson | Executive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary | $2,147,216 |
| Michelle Robertson | CFO | $2,147,216 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Former Chairman of the Board, President and Chief Executive Officer | $4,924,092 |
| Michelle Robertson | CFO | $2,469,659 |
| Michelle J. Robertson | Executive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary | $2,469,659 |
| Andrew J. Grethlein | Former Executive Vice President, Chief Operating Officer | $2,415,091 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Former Chairman of the Board, President and Chief Executive Officer | $2,997,202 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $1,371,749 |
| Olivia Bloom | Executive Vice President, Finance, Chief Financial Officer and Treasurer | $1,350,574 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Chairman of the Board, President and Chief Executive Officer | $2,056,987 |
| Aleksandra Rizo | M.D., Ph.D. Executive Vice President, Chief Medical Officer | $1,265,100 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $1,165,648 |
| Melissa A. Kelly Behrs | Executive Vice President, Business Operations and Chief Alliance Officer | $1,151,590 |
| Olivia Bloom | Executive Vice President, Finance, Chief Financial Officer and Treasurer | $1,141,645 |
| Anil Kapur | Executive Vice President, Corporate Strategy and Chief Commercial Officer | $1,053,262 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Chairman of the Board, President and Chief Executive Officer | $1,876,209 |
| Aleksandra Rizo | M.D., Ph.D. Executive Vice President, Chief Medical Officer | $1,134,946 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $1,034,173 |
| Melissa A. Kelly Behrs | Executive Vice President, Business Operations and Chief Alliance Officer | $1,007,468 |
| Olivia Bloom | Executive Vice President, Finance, Chief Financial Officer and Treasurer | $1,004,199 |
| Anil Kapur | Executive Vice President, Corporate Strategy and Chief Commercial Officer | $673,632 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Chairman of the Board, President and Chief Executive Officer | $1,941,135 |
| Aleksandra Rizo | M.D., Ph.D. Executive Vice President, Chief Medical Officer | $1,531,454 |
| Anil Kapur | Executive Vice President, Corporate Strategy and Chief Commercial Officer | $1,222,260 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $930,994 |
| Olivia Bloom | Executive Vice President, Finance, Chief Financial Officer and Treasurer | $912,467 |
| Melissa A. Kelly Behrs | Executive Vice President, Business Operations and Chief Alliance Officer | $898,657 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Chairman of the Board, President and Chief Executive Officer | $2,772,509 |
| Olivia Bloom | Executive Vice President, Finance, Chief Financial Officer and Treasurer | $1,224,254 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $1,150,235 |
| Melissa A. Kelly Behrs | Executive Vice President, Chief Business Officer | $1,107,021 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| John Scarlett | Chairman of the Board, President and Chief Executive Officer | $2,719,310 |
| Andrew J. Grethlein | Executive Vice President, Chief Operating Officer | $1,123,629 |
| Olivia Bloom | Executive Vice President, Finance, Chief Financial Officer and Treasurer | $1,103,988 |
| Melissa A. Kelly Behrs | Executive Vice President, Chief Business Officer | $1,078,542 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Constantine Chinoporos | Class III director | Appointed | 2026-05-27 |
| Patricia S. Andrews | Class III director | Appointed | 2026-05-27 |
| Susan M. Molineaux | Class III director | Appointed | 2026-05-27 |
| Constantine Chinoporos | Class III director | Appointed | 2026-03-26 |
| Patricia S. Andrews | Class III director | Appointed | 2026-03-26 |
| Ahmed ElNawawi | Executive Vice President, Chief Commercial Officer | Appointed | 2025-10-14 |
| Jim Ziegler | Executive Vice President, Chief Commercial Officer | Resigned | 2025-10-14 |
| Andrew J. Grethlein, Ph.D. | Executive Vice President, Chief Operating Officer | Resigned | 2025-10-14 |
| Gaurav Aggarwal, M.D. | Director | Resigned | 2025-10-14 |
| Harout Semerjian | Class I director | Appointed | 2025-08-06 |
| Harout Semerjian | President and Chief Executive Officer | Appointed | 2025-08-06 |
| Elizabeth G. O’Farrell | Class II director | Appointed | 2025-05-27 |
| Dawn C. Bir | Class II director | Appointed | 2025-05-27 |
| Elizabeth G. O'Farrell | Chair of the Board | Appointed | 2025-03-11 |
| Dawn C. Bir | Interim President and Chief Executive Officer | Appointed | 2025-03-11 |
| John A. Scarlett, M.D. | Chairman of the Board of Directors | Resigned | 2025-03-11 |
| John A. Scarlett, M.D. | President, Chief Executive Officer and Chairman of the Board of Directors | Resigned | 2025-03-11 |
| Gaurav Aggarwal, M.D. | Class III Board member | Appointed | 2023-11-28 |
| Olivia K. Bloom | Executive Vice President, Chief Financial Officer and Treasurer | Retired | 2023-09-12 |
| Michelle J. Robertson | Executive Vice President, Chief Financial Officer and Treasurer | Appointed | 2023-09-12 |
| Karin Eastham | former Lead Independent Director, and a member of the Audit Committee and Compensation Committee of the Board | Retired | 2023-06-02 |
| Elizabeth G. O'Farrell | Lead Independent Director | Appointed | 2023-06-02 |
| Susan M. Molineaux | Class III member of the Board of Directors | Appointed | 2023-06-02 |
| V. Bryan Lawlis | Class III member of the Board of Directors | Appointed | 2023-06-02 |
| Karin Eastham | Class III member of the Company's Board | Retired | 2023-02-23 |
Key facts
CIK
886744
CUSIP
374163103
13F (30d)
250 filings
247 filers
Visit website
Investor relations